Click for best price
Biologic Drugs Market Size, Share 2022
Market Analysis and Insights: Global Biologic Drugs Market
The global Biologic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Drugs market.
Global Biologic Drugs Scope and Market Size
Biologic Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Biologic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Segment by Application
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
By Company
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Biologic Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Biologic Drugs, with price, sales, revenue, and global market share of Biologic Drugs from 2019 to 2022.
Chapter 3, the Biologic Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biologic Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Biologic Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologic Drugs.
Chapter 13, 14, and 15, to describe Biologic Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Biologic Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global Biologic Drugs Market Insights, Forecast to 2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
105 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Biologic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Biologic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Humira
1.2.3 Remicade
1.2.4 Rituxan
1.2.5 Enbrel
1.2.6 Lantus
1.2.7 Avastin
1.2.8 Herceptin
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diabetes
1.3.3 Inflammation
1.3.4 Auto-Immune Diseases
1.3.5 Blood Diseases
1.3.6 Cardiovascular Diseases
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Biologic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Biologic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Biologic Drugs Sales by Region
2.4.1 Global Biologic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Biologic Drugs by Region (2023-2028)
2.5 Global Biologic Drugs Revenue by Region
2.5.1 Global Biologic Drugs Revenue by Region (2017-2022)
2.5.2 Global Biologic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Biologic Drugs Sales by Manufacturers
3.1.1 Global Top Biologic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Biologic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biologic Drugs in 2021
3.2 Global Biologic Drugs Revenue by Manufacturers
3.2.1 Global Biologic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Biologic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Biologic Drugs Revenue in 2021
3.3 Global Biologic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Biologic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biologic Drugs Sales by Type
4.1.1 Global Biologic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Biologic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Biologic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Biologic Drugs Revenue by Type
4.2.1 Global Biologic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Biologic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Biologic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Biologic Drugs Price by Type
4.3.1 Global Biologic Drugs Price by Type (2017-2022)
4.3.2 Global Biologic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Biologic Drugs Sales by Application
5.1.1 Global Biologic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Biologic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Biologic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Biologic Drugs Revenue by Application
5.2.1 Global Biologic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Biologic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Biologic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Biologic Drugs Price by Application
5.3.1 Global Biologic Drugs Price by Application (2017-2022)
5.3.2 Global Biologic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Biologic Drugs Market Size by Type
6.1.1 North America Biologic Drugs Sales by Type (2017-2028)
6.1.2 North America Biologic Drugs Revenue by Type (2017-2028)
6.2 North America Biologic Drugs Market Size by Application
6.2.1 North America Biologic Drugs Sales by Application (2017-2028)
6.2.2 North America Biologic Drugs Revenue by Application (2017-2028)
6.3 North America Biologic Drugs Market Size by Country
6.3.1 North America Biologic Drugs Sales by Country (2017-2028)
6.3.2 North America Biologic Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Biologic Drugs Market Size by Type
7.1.1 Europe Biologic Drugs Sales by Type (2017-2028)
7.1.2 Europe Biologic Drugs Revenue by Type (2017-2028)
7.2 Europe Biologic Drugs Market Size by Application
7.2.1 Europe Biologic Drugs Sales by Application (2017-2028)
7.2.2 Europe Biologic Drugs Revenue by Application (2017-2028)
7.3 Europe Biologic Drugs Market Size by Country
7.3.1 Europe Biologic Drugs Sales by Country (2017-2028)
7.3.2 Europe Biologic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Biologic Drugs Market Size by Type
8.1.1 Asia Pacific Biologic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Biologic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Biologic Drugs Market Size by Application
8.2.1 Asia Pacific Biologic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Biologic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Biologic Drugs Market Size by Region
8.3.1 Asia Pacific Biologic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Biologic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Biologic Drugs Market Size by Type
9.1.1 Latin America Biologic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Biologic Drugs Revenue by Type (2017-2028)
9.2 Latin America Biologic Drugs Market Size by Application
9.2.1 Latin America Biologic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Biologic Drugs Revenue by Application (2017-2028)
9.3 Latin America Biologic Drugs Market Size by Country
9.3.1 Latin America Biologic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Biologic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biologic Drugs Market Size by Type
10.1.1 Middle East and Africa Biologic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Biologic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Biologic Drugs Market Size by Application
10.2.1 Middle East and Africa Biologic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Biologic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Biologic Drugs Market Size by Country
10.3.1 Middle East and Africa Biologic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Biologic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Overview
11.1.3 Roche Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Roche Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Merck & Co.
11.4.1 Merck & Co. Corporation Information
11.4.2 Merck & Co. Overview
11.4.3 Merck & Co. Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Merck & Co. Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck & Co. Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Amgen
11.6.1 Amgen Corporation Information
11.6.2 Amgen Overview
11.6.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Amgen Recent Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Sanofi Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Novartis Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Novartis Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Overview
11.9.3 Eli Lilly Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly Recent Developments
11.10 Amgen
11.10.1 Amgen Corporation Information
11.10.2 Amgen Overview
11.10.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Amgen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biologic Drugs Industry Chain Analysis
12.2 Biologic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biologic Drugs Production Mode & Process
12.4 Biologic Drugs Sales and Marketing
12.4.1 Biologic Drugs Sales Channels
12.4.2 Biologic Drugs Distributors
12.5 Biologic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Biologic Drugs Industry Trends
13.2 Biologic Drugs Market Drivers
13.3 Biologic Drugs Market Challenges
13.4 Biologic Drugs Market Restraints
14 Key Findings in The Global Biologic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Biologic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Humira
Table 3. Major Manufacturers of Remicade
Table 4. Major Manufacturers of Rituxan
Table 5. Major Manufacturers of Enbrel
Table 6. Major Manufacturers of Lantus
Table 7. Major Manufacturers of Avastin
Table 8. Major Manufacturers of Herceptin
Table 9. Major Manufacturers of Others
Table 10. Global Biologic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Biologic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Biologic Drugs Sales by Region (2017-2022) & (K Units)
Table 13. Global Biologic Drugs Sales Market Share by Region (2017-2022)
Table 14. Global Biologic Drugs Sales by Region (2023-2028) & (K Units)
Table 15. Global Biologic Drugs Sales Market Share by Region (2023-2028)
Table 16. Global Biologic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Biologic Drugs Revenue Market Share by Region (2017-2022)
Table 18. Global Biologic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Biologic Drugs Revenue Market Share by Region (2023-2028)
Table 20. Global Biologic Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Biologic Drugs Sales Share by Manufacturers (2017-2022)
Table 22. Global Biologic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Global Biologic Drugs Revenue Share by Manufacturers (2017-2022)
Table 24. Biologic Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 25. Global Biologic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Biologic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Drugs as of 2021)
Table 27. Biologic Drugs Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Biologic Drugs Product Offered
Table 29. Date of Manufacturers Enter into Biologic Drugs Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 32. Global Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 33. Global Biologic Drugs Sales Share by Type (2017-2022)
Table 34. Global Biologic Drugs Sales Share by Type (2023-2028)
Table 35. Global Biologic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 36. Global Biologic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 37. Global Biologic Drugs Revenue Share by Type (2017-2022)
Table 38. Global Biologic Drugs Revenue Share by Type (2023-2028)
Table 39. Biologic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 40. Global Biologic Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 41. Global Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 42. Global Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 43. Global Biologic Drugs Sales Share by Application (2017-2022)
Table 44. Global Biologic Drugs Sales Share by Application (2023-2028)
Table 45. Global Biologic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 46. Global Biologic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 47. Global Biologic Drugs Revenue Share by Application (2017-2022)
Table 48. Global Biologic Drugs Revenue Share by Application (2023-2028)
Table 49. Biologic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 50. Global Biologic Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 51. North America Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 52. North America Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 53. North America Biologic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 54. North America Biologic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 55. North America Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 56. North America Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 57. North America Biologic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 58. North America Biologic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 59. North America Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 60. North America Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 61. North America Biologic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 62. North America Biologic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 63. Europe Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 64. Europe Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 65. Europe Biologic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 66. Europe Biologic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 67. Europe Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 68. Europe Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 69. Europe Biologic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 70. Europe Biologic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 71. Europe Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 72. Europe Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 73. Europe Biologic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 74. Europe Biologic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 75. Asia Pacific Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 76. Asia Pacific Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 77. Asia Pacific Biologic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 78. Asia Pacific Biologic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 79. Asia Pacific Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 80. Asia Pacific Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 81. Asia Pacific Biologic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 82. Asia Pacific Biologic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 83. Asia Pacific Biologic Drugs Sales by Region (2017-2022) & (K Units)
Table 84. Asia Pacific Biologic Drugs Sales by Region (2023-2028) & (K Units)
Table 85. Asia Pacific Biologic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 86. Asia Pacific Biologic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 87. Latin America Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 88. Latin America Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 89. Latin America Biologic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 90. Latin America Biologic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 91. Latin America Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 92. Latin America Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 93. Latin America Biologic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 94. Latin America Biologic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 95. Latin America Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 96. Latin America Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 97. Latin America Biologic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 98. Latin America Biologic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Biologic Drugs Sales by Type (2017-2022) & (K Units)
Table 100. Middle East and Africa Biologic Drugs Sales by Type (2023-2028) & (K Units)
Table 101. Middle East and Africa Biologic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Biologic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Biologic Drugs Sales by Application (2017-2022) & (K Units)
Table 104. Middle East and Africa Biologic Drugs Sales by Application (2023-2028) & (K Units)
Table 105. Middle East and Africa Biologic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Biologic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Biologic Drugs Sales by Country (2017-2022) & (K Units)
Table 108. Middle East and Africa Biologic Drugs Sales by Country (2023-2028) & (K Units)
Table 109. Middle East and Africa Biologic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 110. Middle East and Africa Biologic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 111. Roche Corporation Information
Table 112. Roche Description and Major Businesses
Table 113. Roche Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. Roche Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Roche Recent Developments
Table 116. Abbott Laboratories Corporation Information
Table 117. Abbott Laboratories Description and Major Businesses
Table 118. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Abbott Laboratories Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Abbott Laboratories Recent Developments
Table 121. Johnson & Johnson Corporation Information
Table 122. Johnson & Johnson Description and Major Businesses
Table 123. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. Johnson & Johnson Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Johnson & Johnson Recent Developments
Table 126. Merck & Co. Corporation Information
Table 127. Merck & Co. Description and Major Businesses
Table 128. Merck & Co. Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Merck & Co. Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Merck & Co. Recent Developments
Table 131. Pfizer Corporation Information
Table 132. Pfizer Description and Major Businesses
Table 133. Pfizer Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Pfizer Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Pfizer Recent Developments
Table 136. Amgen Corporation Information
Table 137. Amgen Description and Major Businesses
Table 138. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Amgen Recent Developments
Table 141. Sanofi Corporation Information
Table 142. Sanofi Description and Major Businesses
Table 143. Sanofi Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Sanofi Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Sanofi Recent Developments
Table 146. Novartis Corporation Information
Table 147. Novartis Description and Major Businesses
Table 148. Novartis Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 149. Novartis Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Novartis Recent Developments
Table 151. Eli Lilly Corporation Information
Table 152. Eli Lilly Description and Major Businesses
Table 153. Eli Lilly Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 154. Eli Lilly Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Eli Lilly Recent Developments
Table 156. Amgen Corporation Information
Table 157. Amgen Description and Major Businesses
Table 158. Amgen Biologic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 159. Amgen Biologic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Amgen Recent Developments
Table 161. Key Raw Materials Lists
Table 162. Raw Materials Key Suppliers Lists
Table 163. Biologic Drugs Distributors List
Table 164. Biologic Drugs Customers List
Table 165. Biologic Drugs Market Trends
Table 166. Biologic Drugs Market Drivers
Table 167. Biologic Drugs Market Challenges
Table 168. Biologic Drugs Market Restraints
Table 169. Research Programs/Design for This Report
Table 170. Key Data Information from Secondary Sources
Table 171. Key Data Information from Primary Sources
List of Figures
Figure 1. Biologic Drugs Product Picture
Figure 3. Global Biologic Drugs Market Share by Type in 2021 & 2028
Figure 3. Humira Product Picture
Figure 4. Remicade Product Picture
Figure 5. Rituxan Product Picture
Figure 6. Enbrel Product Picture
Figure 7. Lantus Product Picture
Figure 8. Avastin Product Picture
Figure 9. Herceptin Product Picture
Figure 10. Others Product Picture
Figure 11. Global Biologic Drugs Market Share by Application in 2021 & 2028
Figure 12. Diabetes
Figure 13. Inflammation
Figure 14. Auto-Immune Diseases
Figure 15. Blood Diseases
Figure 16. Cardiovascular Diseases
Figure 17. Others
Figure 18. Biologic Drugs Report Years Considered
Figure 19. Global Biologic Drugs Sales 2017-2028 (K Units)
Figure 20. Global Biologic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Biologic Drugs Revenue 2017-2028 (US$ Million)
Figure 22. Global Biologic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Biologic Drugs Sales Market Share by Region (2017-2022)
Figure 24. Global Biologic Drugs Sales Market Share by Region (2023-2028)
Figure 25. North America Biologic Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. North America Biologic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Biologic Drugs Sales YoY (2017-2028) & (K Units)
Figure 28. Europe Biologic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Biologic Drugs Sales YoY (2017-2028) & (K Units)
Figure 30. Asia-Pacific Biologic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Biologic Drugs Sales YoY (2017-2028) & (K Units)
Figure 32. Latin America Biologic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Biologic Drugs Sales YoY (2017-2028) & (K Units)
Figure 34. Middle East & Africa Biologic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Biologic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Biologic Drugs in the World: Market Share by Biologic Drugs Revenue in 2021
Figure 37. Global Biologic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 39. Global Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 40. Global Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 41. Global Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 42. North America Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 43. North America Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 44. North America Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 45. North America Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 46. North America Biologic Drugs Sales Share by Country (2017-2028)
Figure 47. North America Biologic Drugs Revenue Share by Country (2017-2028)
Figure 48. U.S. Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 51. Europe Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 52. Europe Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 53. Europe Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 54. Europe Biologic Drugs Sales Share by Country (2017-2028)
Figure 55. Europe Biologic Drugs Revenue Share by Country (2017-2028)
Figure 56. Germany Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. France Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Biologic Drugs Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Biologic Drugs Revenue Share by Region (2017-2028)
Figure 67. China Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. India Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 77. Latin America Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 79. Latin America Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Biologic Drugs Sales Share by Country (2017-2028)
Figure 81. Latin America Biologic Drugs Revenue Share by Country (2017-2028)
Figure 82. Mexico Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Middle East and Africa Biologic Drugs Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Biologic Drugs Revenue Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Biologic Drugs Sales Market Share by Application (2017-2028)
Figure 88. Middle East and Africa Biologic Drugs Revenue Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Biologic Drugs Sales Share by Country (2017-2028)
Figure 90. Middle East and Africa Biologic Drugs Revenue Share by Country (2017-2028)
Figure 91. Turkey Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 92. Saudi Arabia Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 93. UAE Biologic Drugs Revenue (2017-2028) & (US$ Million)
Figure 94. Biologic Drugs Value Chain
Figure 95. Biologic Drugs Production Process
Figure 96. Channels of Distribution
Figure 97. Distributors Profiles
Figure 98. Bottom-up and Top-down Approaches for This Report
Figure 99. Data Triangulation
Figure 100. Key Executives Interviewed
